A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1)

NCT01379300 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: dabigatran etexilate
DRUG: rivaroxaban

Sponsor

Merck Sharp & Dohme LLC